Abbott Laboratories urged a U.S. appeals court to throw out a $1.67 billion patent-infringement verdict, the largest in U.S. history, set after a jury found the company used Johnson & Johnson’s technology to develop the arthritis drug Humira.
Abbott is focusing its appeal on the validity of the patent, co-issued to New York University and J&J’s Centocor unit. Humira, Abbott’s biggest drug, includes human antibodies that aren’t covered by the patent, a lawyer for the Abbott Park, Illinois-based company said.
via bloomberg.com
No comments:
Post a Comment